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A radioimmunoassay was developed that can detect and quantitate 3 ng or
more of the avian RNA tumor virus reverse transcriptase. The assay detected no
antigenic sites in Rous sarcoma virus a virions or in virions of a murine RNA
tumor virus. About 70 molecules of reverse transcriptase were found per virion of
avian myeloblastosis virus with this assay or with an assay based on antibody
inhibition of enzymatic activity. The assay detected about 270 ng of enzyme per
mg of cell protein in virus-producing cells; uninfected cells had much less
antigenic material but contained some determinants able to displace radioactive
antigen. No additional antigenic determinants on reverse transcriptase could be
detected that were not found on the separated a subunit of the enzyme.
Although sevenfold less sensitive than enzymatic activity as a measure of reverse
transcriptase, the radioimmunoassay can detect antigen using small amounts
of protein and in the presence of inhibitors.
Radioimmunoassay (RIA) is a powerful tool
for detection and quantitation of the proteins of
RNA tumor viruses (4, 20, 22). The assay has
been especially useful for studying the relative
amounts of different viral proteins in produc-
tively infected cells or in nonproducing cells
that express some viral genetic information (5,
21).
Three major classes of proteins are known to
be encoded by the genomes of avian RNA tumor
viruses (1): the internal low-molecular-weight
proteins that derive from a 76,000-dalton pre-
cursor (26); the glycoprotein of about 80,000
daltons (3); and the reverse transcriptase (24)
that is apparently derived from a single 100,000-
dalton subunit (7, 17). Although the internal
proteins and the murine glycoprotein have been
studied by RIA, the reverse transcriptase has
previously been detected only by its DNA
polymerase or RNase H activity (2, 24, 28). We
have now developed an RIA for the reverse
transcriptase of avian RNA tumor viruses. With
this assay, the enzyme can be detected in the
presence of inhibitors and accurately quan-
titated independent of the vagaries of en-
zymatic assay.
MATERIALS AND METHODS
Viruses. Avian myeloblastosis virus (AMV) strain
A was obtained from J. W. Beard through the Virus
'Present address: Department of Virology, Hebrew Uni-
versity, Hadassah Medical School, Jerusalem, Israel.
Cancer Program of the National Cancer Institute.
Rous sarcoma virus a (RSVa) was obtained as de-
scribed previously (11). The Schmidt-Ruppin strain
of RSV, subgroup A, was propagated on secondary
chicken embryo fibroblasts obtained from SPAFAS
(14). Moloney murine leukemia virus was grown as
described previously (6). All viruses were purified on
stepwise sucrose gradients (25) and banded again on
25 to 45% linear sucrose gradients (6).
Cells. Normal chicken embryo fibroblasts(gs-h-)
were characterized as described previously (5).
Schmidt-Ruppin RSV subgroup A-infected chicken
embryo fibroblasts and JLS V-9 cells were grown as
described previously (ref. 14 and 6, respectively).
Cellular extracts. Confluent monolayers were har-
vested with trypsin and the cells were washed three to
five times with phosphate-buffered saline, pH 7.4
(PBS). Cell pellets were suspended in PBS containing
0.5% Nonidet P-40, 10 mM dithiothreitol, and 10%
glycerol and were homogenized with a glass Dounce
homogenizer. The nuclei were removed by centrifuga-
tion for 4 min at 1,000 x g. The supernatant was
extracted three times with ether, dialyzed against
PBS, and used for RIA.
Purification of reverse transcriptase. AMV' re-
verse transcriptase was purified by chromatography
on DEAE-Sephadex and phosphocellulose columns as
described previously (25). The smaller subunit (a)
was obtained as the peak eluting first from the
phosphocellulose column (8). The holoenzyme (a, ,B)
fraction from the phosphocellulose column was con-
centrated on a small phosphocellulose column and
further purified by applying 1 ml of the concentrated
enzyme to a Sephadex G-100 column (0.9 by 60 cm)
equilibrated with 50 mM Tris-hydrochloride (pH 8.0),
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0.2 M KCl, 0.01% Nonidet P-40, 0.5 mM dithio-
threitol, 0.1 mM EDTA, and 20% glycerol. The
reverse transcriptase activity, which eluted in the
void volume of the column, was dialyzed extensively
against 20 mM potassium phosphate (pH 7.5)-150
mM KCl and then dialyzed against 5 mM potassium
phosphate (pH 7.5). It was then lyophilized and the
residue was redissolved in 30 Ml of water. The purity of
the reverse transcriptase was analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(Fig. 1). The preparation was shown to consist of two
subunits (a and ,B) with a minor presumed contami-
nant between these two bands.
Iodination of reverse transcriptase. Iodination
was carried out as described by Greenwood et al. (9).
Reaction mixture (35 Al) contained 5 Mg of reverse
transcriptase, 500 MCi of Na125I, and 4 Mg of chloram-
ine T and was incubated for 15 min at 2 C. The
product was separated from free Na125I by chromatog-
raphy on a BioGel P-30 column. The iodinated
enzyme was further purified by gel chromatography
on a Sephadex G-200 column (1.2 by 70 cm) equili-
brated with 50 mM Tris-hydrochloride (pH 8), 0.2 M
KCl, 0.02% Nonidet P-40, 0.5 mM dithiothreitol, 0.1
mM EDTA, 20% glycerol, and 50 Mg of bovine serum
albumin per ml. The first radioactive peak eluted
from the column was used for the RIA. All of the
radioactivity could be precipitated with 5% trichloro-
acetic acid. This radioactive product was analyzed by
sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and was shown by autoradiography to consist
solely of the two subunits (a and s) of reverse
transcriptase.
RIA for reverse transcriptase. Reaction mixtures
(500 Ml) contained PBS, 500 Ag of bovine serum
albumin, 0.1% Nonidet P-40, 0.25% normal rat serum,
rat anti-AMV reverse transcriptase serum at the
dilution indicated in the legends to the figures,
and the sample tested for the presence of reverse
transcriptase. After incubation for 1 h at 37 C,
125I-labeled reverse transcriptase was added (10,000
counts/min), and incubation continued for another
hour at 37 C followed by 18 h at 4 C. EDTA (0.1 mM)
and 30Ml of rabbit anti-rat immunoglobulin G serum
were added, followed by incubation for 1 h at 37 C and
4 h at 4 C. The precipitate was collected by centrifu-
gation, washed twice with PBS containing 1 mg of
bovine serum albumin per ml and 0.1% Nonidet P-40,
and radioactivity was counted in a gamma ray
counter. A 5% background was subtracted, and 100%
precipitation represents the amount of radiolabeled
reverse transcriptase precipitated in the absence of
any competing antigen.
DNA polymerase activity. Reaction mixtures (100
Ml) contained 50 mM Tris-hydrochloride (pH 8.3), 6
mM MgCl2, 5 mM dithiothreitol, 0.1 mM [3H]dGTP
(100 counts/min per pmol), 2 Mg of poly(C), 0.5 jg of
oligo(dG)1, -., and reverse transcriptase as indicated.
The mixtures were incubated at 37 C and reactions
were stopped by adding 5% trichloroacetic acid.
Protein concentrations were determined as de-
scribed by Lowry et al. (16), with bovine serum
albumin as standard protein.
Materials. Na125I and [8H ]dGTP were purchased
-Origin
- 94,000
-68,000
-43,000
-26,000
- Dye
FIG. 1. Sodium dodecyl sulfate-gel electrophoresis
of purified reverse transcriptase. AMV reverse tran-
scriptase (Sephadex G-100 fraction) was subjected to
electrophoresis on slab, 10%o sodium dodecyl sulfate-
polyacrylamide gel according to Laemli (15). The gel
was stained with Coomassie blue. The following
proteins were used as markers: phosphorylase a, mol
wt 94,000; bovine serum albumin, mol wt 68,000;
ovalbumin, mol wt 43,000; and chymotrypsinogen,
mol wt 26,000.
from New England Nuclear Corp. Rabbit anti-rat
immunoglobulin G serum and normal rat serum were
Miles Corp. products. Rat anti-AMV reverse tran-
scriptase serum was a kind gift from R. Nowinski,
University of Wisconsin, Madison.
RESULTS
Immunoprecipitation of reverse transcript-
ase and its inhibition. To develop an RIA for
the AMV reverse transcriptase, we used a
monospecific antiserum made in a rat against
the enzyme. This serum had previously been
shown to inhibit the enzymatic activities of the
avian RNA tumor virus reverse transcriptase
(18, 27). The ability of various dilutions of the
antiserum to precipitate [125I ]AMV reverse
transcriptase is shown in Fig. 2. With high
antiserum concentrations, 87% of the labeled
enzyme was precipitated (if the Sephadex
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G-200 column chromatography after iodination
was omitted, only 35%c was precipitable). Serum
f'rom an unimmunized rat precipitated only 5%7(
of' the labeled enzvme.
From the data in Fig. 2, an amount of
antiserum was determined that would precipi-
tate 55%e of' the labeled enzyme. Competition of
this precipitation was studied by incubating
increasing amounts of' unlabeled enzyme with
the antiserum before using it to precipitate the
labeled protein (Fig. 3). With this svstem, 3 to 5
ng of' reverse transcriptase could be detected.
Specificity of the assay. Using disrupted
virions for competition, both AMV and RSV
were eff'ective competitors (Fig. 4). Whereas
AMV enzyme or virions could completely com-
pete with the labeled AMV enzyme, RSV vi-
rions could not displace about 13`7( of' the
labeled AMV enzyme, presumably reflecting
some type-specific determinants.
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FIG. 3. Dose response of AMV reverse transcript-
ase, a and a,f3 forms. Reactions were performed as
described in the text with increasing amounts of the
smaller subunit (a) (phosphocellulose fraction) or a,#3
(Sephadex G-100 fraction). Anti-reverse transcriptase
serum was added at a 1:25,000 dilution, which gave
55% precipitation of '265-labeled reverse transcriptase
(12,000 counts/min).
iutant that had previously been previous studies (18). To determine whether the
as lacking detectable reverse murine enzyme would compete in the RIA,
y using either enzymatic assay or various amounts of' disrupted virions of Mo-
r antibody able to inhibit AMV loney mouse leukemia virus were used as com-
se activity (10, 18). Use of virions petitors; no inhibition of' precipitation of the
present RIA showed no detecta- AMV enzyme was seen (Fig. 4).
Df precipitation (Fig. 4), support- Quantity of reverse transcriptase in
ntion that RSVa lacks reverse virions. The ability of disrupted virions and
nd demonstrating the ability Of homogeneous reverse transcriptase to compete
stinguish among the virion pro- in the RIA was determined (Fig. 5). From the
displacement of the virion curve as compared
amiused for precipitation showed with the purified enzyme curve, it appears that
activity against the activity
in
about 3.5% of the virion proteins are reverse
nia virus reverse transcriptase in transcriptase.
To verify the amount of reverse transcriptase
in the virions, another immunologic approach
was used. For this, rather than using the anti-
body to precipitate labeled enzyme, the anti-
body was used to inhibit the DNA polymerase
activity of the enzyme and competition with
\ this inhibition was used to quantitate the en-
zyme in unknown or standard preparations. The
\ enzymatic activity of the unknown or standards
was 100% inactivated with N-ethylmaleimide
(NEM) before using them in the competition
assay. NEM, which is a nonreversible inhibitor
0 of the DNA polymerase activity (unpublished
500 5000 50,000 500,000 data), does not appear to affect the antigenicRecproalof serum dilution activity of the enzyme. Excess NEM was de-
Reciprocal of serum dilution
stroyed by dithiothreitol.
snoprecipitation of 125I-labeled reverse A dilution of 1:450 of the antiserum inhibited
eactions were conducted as described 86% of the DNA polymerase activity of a given
th 125I-labeled reverse transcriptase
min) and anti-reverse transcriptase amount of AMV reverse transcriptase using
rsing dilutions as indicated. The mix- poly(C) oligo(dG) as a template primer. The
bated for 1 h at 37 C and 18 h at 4 C curves of restoration of activity by competing
of rabbit anti-rat immunoglobulin G NEM-inactivated pure enzyme or disrupted
Iy). virions are shown in Fig. 6. From the scale
0-a--
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FIG. 4. Detection of reverse transcriptase in AMV
and RSV. RIA was conducted as described in the text
with serum against reverse transcriptase at a 1:37,500
dilution, which gave 50% precipitation of 9,100
counts/min of 1251-labeled reverse transcriptase.
Polymerose AMV
.60X \
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Competing protein (ng)
FIG. 5. Quantitation of reverse transcriptase in
AMV by RIA. Reactions were performed as described
in the text with anti-AMV reverse transcriptase
serum at a 1:25,000 dilution, which precipitated 53%
of "II-labeled reverse transcriptase (12,200 counts!
min).
change necessary to cause overlapping of the two
restoration curves, about 2.2% of the weight of
protein in the virion appears to be reverse
transcriptase. This value agrees reasonably well
with the 3.5% calculated by the RIA.
Detection of reverse transcriptase in crude
ceilular extracts. The RIA was applied to
detect and quantitate reverse transcriptase in
crude cellular extracts. Crude extract prepared
from chicken embryo fibroblasts transformed
by RSV competed effectively with 1251-labeled
reverse transcriptase (Fig. 7) with a slope simi-
lar to that seen for virions of RSV (Fig. 4).
Comparing the competition curves for pure
enzyme and cell extract, the concentration of
reverse transcriptase in the cells was 270 ng per
mg of cell protein. Extract from normal chicken
embryo fibroblasts (gs-h-) could displace some
"2'I-labeled reverse transcriptase, but 10 times
more protein from normal cells, as compared
with RSV-transformed cells, was needed to
displace 20% of 1251-labeled reverse transcript-
ase. Also, the competition curve for normal cells
was shallower than that for transformed cells.
Increasing amounts of crude extract made from
the murine fibroblasts, JLS V-9 cells (29), failed
to cross-react with anti-reverse transcriptase
serum (Fig. 7).
Immunoreactivity of holoenzyme and ac-
tive subunit. AMV reverse transcriptase has
two subunits; a subunit contains both DNA
polymerase and RNase H activity (8), and ,3
subunit has not been purified and is only known
to increase the binding affinity of a to tem-
plate -primer (19). The DNA polymerase activi-
ties of both a and a,B were completely inhibited
by the anti-AMV reverse transcriptase serum
made against a# (Fig. 8). More significantly,
when a and af, were used as competitors in the
RIA with labeled a#, a was able to completely
0
0"l
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cr
AMV Polymerase-NEM ( Lg protein)
0.04 0.08 0.12 0.16 0.20 0.24
I
Polymerose- NEM
l
2 4 6 8 10
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FIG. 6. Neutralization inhibition ofDNA polymer-
ase activity. The DNA polymerase activity in virus or
purified reverse transcriptase was inactivated by
incubation with 3 mM NEM, 50 mM 7ris-hydrochlo-
ride, pH 8.0, 1 mg of bovine serum albumin per ml,
and 1% Nonidet P-40. After 15 min at 4 C, dithio-
threitol (20 mM) was added to destroy excess NEM.
Increasing amounts of antigen-NEM were reacted
with anti-reverse transcriptase serum at a 1:450
dilution in mixtures (45 gl) containing 10 mM Tris-
hydrochloride, pH 8.0, 150 mM KCI, 0.5 mg of bovine
serum albumin per ml, and 10% glycerol. After 20 min
of incubation at 37 C, active purified AMV reverse
transcriptase (25 ng in 5 gl) was added and incubation
was continued for another 20 min at 37 C. The
residual DNA polymerase activity in the mixtures was
determined by adding 50 gl of a mixture of all the
components needed for assaying DNA polymcrase
activity (see text).
° M-MuLV
RSVa(O)
AMV\ \RSV
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FIG. 7. Reverse transcriptase in crude cellular ex-
tracts. RIA with crude extracts was conducted as
described in the text with anti-reverse transcriptase
serum at a 1:20,600 dilution, which precipitated 42%
of 1251-labeled reverse transcriptase (8,200 counts!
min).
displace radiolabeled af: from the precipitate
(Fig. 3). A higher amount of a protein than a:
proteins was needed to give complete competi-
tion, possibly due to either the relative impurity
of a or partial denaturation of a during prepara-
tion. Rechromatography of a preparations has
shown less than 6% of a: contamination, so the
competition seen in Fig. 3 could not be due to
af3 in the a preparations. We conclude from
these results that there are no antigenic deter-
minants for precipitation of a# that are not also
present on a alone.
Comparison of radioimmunoassay to enzy-
matic assay of DNA polymerase. To compare
the sensitivity of the RIA to the direct determi-
nation of reverse transcriptase by DNA polym-
erase assay, the amount of enzyme needed for a
20% competition in the RIA was compared with
the amount required to catalyze the incorpora-
tion of 5 pmol of dGMP with poly(C) -oligo(dG)
as the template -primer. The enzymatic assay
was sevenfold more sensitive for the pure en-
zyme (Table 1). In the disrupted virions, the
enzymatic assay was ninefold more sensitive
(Table 1), indicating that purification of the
enzyme does not lead to marked inactivation or
activation.
The advantage of RIA over enzyme assay
comes when cell extracts are being studied.
Inhibitors of DNA polymerase activity in crude
extracts can mask or alter enzyme activity in
extracts, but the immunologic assay is not
affected. We have previously used enzyme as-
says after phosphoscellulose chromatography to
quantitate in vivo reverse transcriptase (2), but
this requires a few milligrams of protein
whereas the RIA of RSV-transformed cells can
be carried out with 11 ug of cell protein (Table
1).
DISCUSSION
By using a rat antiserum made against the
AMV reverse transcriptase and 1251-labeled pure
enzyme, an RIA for reverse transcriptase has
been developed that can detect 3 to 5 ng of the
enzyme. This level of sensitivity is comparable
with that of RIAs used to detect other viral
proteins such as p30 and gp7O (4, 22).
Monospecific antiserum against AMV reverse
transcriptase was shown by Nowinski et al. (18)
to inhibit the DNA polymerase activities of the
enzymes from both AMV and RSV, suggesting
that the active sites of the two enzymes were
similar. By using the RIA for analysis of reverse
transcriptase, we confirmed the cross-reaction
of the two enzymes, but we were also able to
detect a small proportion of antigenic sites on
the AMV enzyme not found on the RSV en-
zyme. The extensive homology between AMV
and RSV reverse transcriptase enabled us to use
the same RIA for the detection of both enzymes
in crude extracts. When assaying RSV-infected
V00
50
c5
'a
0.1 0.2 0.3 0.4
Anti-reverse Transcriptase Serum (mg Protein)
FIG. 8. Inhibition ofDNA polymerase activity in a
and a,f# forms of reverse transcriptase by monospe-
cific antibodies. The reactions were conducted in two
steps: (i) neutralization of reverse transcriptase by
antibodies; and (ii) assay for residual DNA polymer-
ase activity. The initial reaction mixtures (50 ,il)
contained 10mM Tris-hydrochloride, pH8.3, 150mM
KCI, 20% glycerol, 50 ,gg of bovine serum albumin, 50
units of enzyme a subunit (0) or a,I# form (0), and
rat anti-AMV reverse transcriptase serum. Incubation
for 10 min at room temperature was followed by assay
of the residual polymerase activity as described in the
text.
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TABLE 1. Comparison of RIA to DNA polymerase
assay for detection of reverse transcriptase
Amt of protein (ng)
Source of enzyme detected by: Ratio
R DNA poly-merase assay"
Purified reverse tran-
scriptase 5 0.7 7
AMV 80 8.5 9
RSV 180 20.5 9
RSV-transformed
CEF extractc 11,500 No activity
a Amount of protein needed for displacement of 20%
of '25I-labeled reverse transcriptase in RIA (see Fig. 4
and 7).
° Amount of protein needed to catalyze the incorpo-
ration of 5 pmol of ['H]dGTP (500 counts/min) in 60
min under standard conditions (see text).
c CEF, Chicken embryo fibroblast.
cells (Fig. 7), the AMV type-specific determi-
nants were not evident, suggesting that they
may be present on proteins in infected cells but
not on the DNA polymerase packaged in virions
of RSV.
By using the antibody to reverse transcriptase
either in the RIA or in an assay based on
inhibition of enzyme activity, the amount of
enzyme in virions was assessed. The enzyme
comprised about 3% of the AMV virion protein
by either assay. The molecular weight of the
enzyme is about 160,000 (13); assuming that
the virion contains 3.8 x 108 daltons of protein
(23), there would be about 70 molecules of
enzyme per virion. Schmidt-Ruppin RSV vi-
rions appear to have about 40% of the enzyme
found in AMV (Table 1); the difference may or
may not be real, however, because plasma-
derived AMV is being compared with RSV from
chicken embryo cell cultures. Kacian et al. (13)
estimated that AMV virions have only 5 to 17
molecules of reverse transcriptase based on the
degree of purification of the enzyme necessary
to reach homogeneity. The difference between
their estimate and ours could be a result of the
different methods used or of the preparations of
virus used. Whatever the explanation, it is
apparent that many molecules of reverse tran-
scriptase are present in each virion.
The level of reverse transcriptase in the
infected cells we studied was about 270 ng per
mg of cell protein. This is much less than the
values reported for p30 and other virion proteins
in infected cells (4), especially when corrected
to moles of protein per cell. Although these
studies must all be done on the same materials
to be certain of the ratio of the various proteins,
the data suggest that many fewer molecules of
reverse transcriptase are formed than of p30,
p19, and p15 (all three of which are apparently
derived from a single 76,000-dalton precursor).
We were able to detect material that inhib-
ited the RIA in uninfected cells (Fig. 7). These
cells were gs-h-, but all uninfected chick cells
studied by Chen et al. (5) have had p30, so the
inhibition could be due to reverse transcriptase
in uninfected cells. We have recently detected
an activity that could be reverse transcriptase
in uninfected cells using poly(C) .oligo(dG) as
template -primer to direct the synthesis of
poly(dG) (unpublished data). Further study of
this question is required.
AMV reverse transcriptase has been shown to
consist of two polypeptides, a and ,B, with
molecular weights of 60,000 and 100,000, respec-
tively. Reverse transcriptase isolated from vi-
rions can be separated by column chromatogra-
phy into two enzymatically active forms-the
smaller subunit (a) and the holoenzyme (a, ,B)
(8). The two forms have similar enzymatic
activities but differ in their binding affinity to
template -primer complex (19). The ability of
antiserum against the holoenzyme to inhibit the
activity of a confirms the identity of the active
site of these two forms of enzyme. Furthermore,
the ability of the a subunit to displace all of the
1251-labeled a, ( in the RIA suggests that a
contains all of the antigenic determinants of a,
, form. A likely explanation for this phenome-
non is that ,B is very similar to a. Such an
interpretation would agree with the suggestion
that a may be a proteolytic cleavage product of
(3 (17) and the discovery that there are amino
acid sequence similarities between a and p (7).
Even though the RIA for reverse transcriptase
is almost 10-fold less sensitive than assay of
DNA polymerase activity (Table 1), the ability
to quantitate amounts of protein rather than
catalytic activity has certain advantages. Some
of these are evident from the studies reported
here, but the major advantage will come from
analysis of intracellular forms of the enzyme.
ACKNOWLEDGMENTS
This investigation was supported by a Public Health
Service contract from the Virus Cancer Program of the
National Cancer Institute and Public Health Service grants
CA 14051 and CA 14936 from the National Cancer Institute.
D. B. was supported by a Research Professorship from the
American Cancer Society.
We wish to thank R. Nowinski and J. W. Beard for
materials.
LITERATURE CITED
1. Baltimore, D. 1974. Tumor viruses: 1974. Cold Spring
Harbor Symp. Quant. Biol. 39:1187-1200.
VOL. 16, 1975 151
152 PANET, BALTIMORE, AND HANAFUSA
2. Baltimore, D., R. McCaffrey, and D. F. Smoler. 1973.
Properties of reverse transcriptase, p. 51-59. In C. F.
Fox and W. S. Robinson (ed.), Virus research, vol. 17,
Academic Press Inc., New York.
3. Bolognesi, D. P., and H. Bauer. 1970. Polypeptides of
avian RNA tumor viruses. I. Isolation and physical and
chemical analysis. Virology 42:1097-1112.
4. Chen, J. H., and H. Hanafusa. 1974. Detection of a
protein of avian leukoviruses in uninfected chick cells
by radioimmunoassay. J. Virol. 13:340-346.
5. Chen, J. H., W. S. Hayward, and H. Hanafusa. 1974.
Avian tumor virus proteins and ribonucleic acid in
uninfected chicken embryo cells. J. Virol.
14:1419-1429.
6. Fan, H., and D. Baltimore. 1973. RNA metabolism of
murine leukemia virus: detection of virus specific RNA
sequences in infected and uninfected cells and identifi-
cation of virus specific messenger RNA. J. Mol. Biol.
80:93-117.
7. Gibson, W., and I. M. Verma. 1974. Studies on the
reverse transcriptase of RNA tumor viruses. Structural
relatedness of two subunits of avian RNA tumor
viruses. Proc. Natl. Acad. Sci. U.S.A. 71:4991-4994.
8. Grandgenett, D. P., G. F. Gerard, and M. Green. 1973. A
single subunit from avian myeloblastosis virus with
both RNA directed DNA polymerase and ribonuclease
H activity. Proc. Natl. Acad. Sci. U.S.A. 70:230-234.
9. Greenwood, F. C., W. M. Hunter, and J. S. Glover. 1963.
The preparation of 131I labeled human growth hormone
of high specific radioactivity. Biochem. J. 89:114-123.
10. Hanafusa, H., D. Baltimore, D. Smoler, K. F. Watson, A.
Yaniv, and S. Spiegelman. 1972. Absence of polymer-
ase protein in virions of alpha type Rous sarcoma virus.
Science 177:1188-1191.
11. Hanafusa, H., and T. Hanafusa. 1971. Noninfectious
RSV deficient in DNA polymerase. Virology
43:313-316.
12. Hurwitz, J., and J. P. Leis. 1972. RNA-dependent DNA
polymerase activity of RNA tumor viruses. I. Directing
influence of DNA in the reaction. J. Virol. 9:116-129.
13. Kacian, D. L., K. F. Watson, A. Burny, and S. Spiegel-
man. 1971. Purification of the DNA polymerase of
avian myeloblastosis virus. Biochim. Biophys. Acta
246:365-383.
14. Kawai, S., and H. Hanafusa. 1972. Genetic recombina-
tion with avian tumor virus. Virology 49:37-41.
15. Laemmli, U. K. 1970. Cleavage of structural proteins
during the assembly of the head of bacteriophage T4.
Nature (London) 227:680-685.
16. Lowry, 0. H., N. J. Rosebrough, A. L. Farr, and R. J.
Randall. 1951. Protein measurement with the Folin
phenol reagent. J. Biol. Chem. 193:265-275.
17. Moelling, K. 1974. Reverse transcriptase and RNase H
present in a murine virus and in both subunits of
an avian virus. Cold Spring Harbor Symp. Quant.
Biol. 39:969-973.
18. Nowinski, R. C., K. F. Watson, A. Yaniv, and S.
Spiegelman. 1972. Serological analysis of the deoxyri-
bonucleic acid polymer-ase of avian oncornaviruses. II.
Comparison of avian deoxyribonucleic acid polymer-
ases. J. Virol. 10:959-964.
19. Panet, A., I. M. Verma, and D. Baltimore. 1974. Role of
the subunits of the avian RNA tumor virus reverse
transcriptase. Cold Spring Harbor Symp. Quant. Biol.
39:919-923.
20. Stephenson, J. R., S. R. Tronick, and S. A. Aaronson.
1974. Analysis of type specific antigenic determinants
of two structural polypeptides of mouse RNA C-type
viruses. Virology 58:1-8.
21. Stephenson, J. R., R. Wilsnack, and S. A. Aaronson.
1973. Radioimmunoassay for avian C-type virus group-
specific antigen: detection in normal and virus-
transformed cells. J. Virol. 11:893-899.
22. Strand, M., and J. T. August. 1973. Structural proteins
of oncogenic ribonucleic acid viruses. J. Biol. Chem.
248:5627-5633.
23. Stromberg, K., N. E. Hurley, N. L. Davis, R. R.
Rueckert, and E. Fleissner. 1974. Structural studies of
avian myeloblastosis virus: comparison of polypeptides
in virion and core component by dodecyl sulfate-polya-
crylamide gel electrophoresis. J. Virol. 13:513-528.
24. Temin, H. M., and D. Baltimore. 1972. RNA-directed
DNA synthesis and RNA tumor viruses, p. 129-186. In
K. M. Smith and M. A. Lauffer (ed.), Advances in
virus research, vol. 17. Academic Press Inc., New
York.
25. Verma, I. M., and D. Baltimore. 1973. Purification of the
RNA directed DNA polymerase from avian myeloblas-
tosis virus and its assay with polynucleotide templates.
Methods Enzymol. 29:125-131.
26. Vogt, V. M., and R. Eisenman. 1973. Identification of a
large polypeptide precursor of avian oncomavirus pro-
teins. Proc. Natl. Acad. Sci. U.S.A. 70:1734-1738.
27. Watson, K. F., R. C. Nowinski, A. Yaniv, and S.
Spiegelman. 1972. Serological analysis of the deoxyri-
bonucleic acid polymerase of avian oncornaviruses. I.
Preparation and characterization of monospecific anti-
serum with purified deoxyribonucleic acid polymerase.
J. Virol. 10:951-958.
28. Weissbach, A., A. Bolden, R. Muller, H. Hanafusa, and
T. Hanafusa. 1972. Deoxyribonucleic acid polymerase
activities in normal and leukovirus-infected chicken
embryo cells. J. Virol. 10:321-327.
29. Wright, B. S., P. A. O'Brien, G. P. Shibley, S. A.
Mayyasi, and J. C. La Fargues. 1967. Infection of an
established bone marrow cell line JLS V-9 with
Rauscher and Moloney murine leukemia viruses. Can-
cer Res. 27:1672-1677.
J. VIRtOL.
